COMVADIS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
COMVADIS
Largest movements
- Cash +€53,148
up €53,148 (+124%), from €42,955 to €96,103
mainly Net result for the year (+€46,646) and Current investments (+€17,533)
- Current investments -€17,533
down €17,533 (-3.8%), from €464,992 to €447,460
- Receivables within one year +€9,634
up €9,634 (+16.2%), from €59,584 to €69,218
of which Trade receivables: +€9,500
- Profit (loss) carried forward +€46,646
up €46,646 (+79.1%), from -€58,954 to -€12,307
- Gross operating margin +€40,792
up €40,792, from -€2,229 to €38,563
- Financial income +€5,095
up €5,095 (+124%), from €4,095 to €9,189
- Depreciation +€410
new in 2025: €410
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €571,251 | €618,241 | +€46,990 | +8.2% |
| Fixed assets | 21/28 | - | €1,741 | +€1,741 | |
| Tangible fixed assets | 22/27 | - | €1,741 | +€1,741 | |
| Plant, machinery and equipment | 23 | - | €1,741 | +€1,741 | |
| Current assets | 29/58 | €571,251 | €616,500 | +€45,249 | +7.9% |
| Amounts receivable within one year | 40/41 | €59,584 | €69,218 | +€9,634 | +16.2% |
| Trade receivables | 40 | €700 | €10,200 | +€9,500 | +1,357% |
| Other amounts receivable | 41 | €58,884 | €59,018 | +€134 | +0.2% |
| Current investments | 50/53 | €464,992 | €447,460 | -€17,533 | -3.8% |
| Cash at bank and in hand | 54/58 | €42,955 | €96,103 | +€53,148 | +124% |
| Deferred charges and accrued income | 490/1 | €3,720 | €3,720 | = | 0.0% |
| Total equity and liabilities | 10/49 | €571,251 | €618,241 | +€46,990 | +8.2% |
| Equity | 10/15 | €563,046 | €609,693 | +€46,646 | +8.3% |
| Contributions | 10/11 | €620,000 | €620,000 | = | 0.0% |
| Capital | 10 | €620,000 | €620,000 | = | 0.0% |
| Issued capital | 100 | €620,000 | €620,000 | = | 0.0% |
| Reserves | 13 | €2,000 | €2,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,000 | €2,000 | = | 0.0% |
| Legal reserve | 130 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€58,954 | -€12,307 | +€46,646 | +79.1% |
| Amounts payable | 17/49 | €8,205 | €8,548 | +€343 | +4.2% |
| Amounts payable within one year | 42/48 | €8,205 | €8,548 | +€343 | +4.2% |
| Trade debts | 44 | €8,205 | €8,548 | +€343 | +4.2% |
| Suppliers | 440/4 | €8,205 | €8,548 | +€343 | +4.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €410 | +€410 | |
| Other operating charges | 640/8 | €611 | €647 | +€36 | +5.9% |
| Gross operating margin | 9900 | -€2,229 | €38,563 | +€40,792 | |
| Operating profit (loss) | 9901 | -€2,840 | €37,505 | +€40,345 | |
| Financial income | 75/76B | €4,095 | €9,189 | +€5,095 | +124% |
| Recurring financial income | 75 | €4,095 | €9,189 | +€5,095 | +124% |
| Financial charges | 65/66B | €44 | €48 | +€5 | +10.6% |
| Recurring financial charges | 65 | €44 | €48 | +€5 | +10.6% |
| Profit (loss) for the period before taxes | 9903 | €1,211 | €46,646 | +€45,435 | +3,752% |
| Income taxes | 67/77 | -€127 | - | +€127 | |
| Profit (loss) for the period | 9904 | €1,338 | €46,646 | +€45,308 | +3,386% |
| Profit (loss) for the period to be appropriated | 9905 | €1,338 | €46,646 | +€45,308 | +3,386% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.